10-Q: CNO Financial Group Reports Strong Q2 2026 Results

CNO Financial Group announced improved operating earnings and raised its full-year guidance, driven by growth across its insurance product lines and effective investment management.

Summary

• CNO Financial Group reported net income of $125.9 million for Q2 2026, a significant increase from $91.8 million in Q2 2025. For the first six months of 2026, net income was $163.6 million, up from $113.3 million in the same period of 2025.
• Operating earnings per diluted share guidance for the full year 2026 has been raised to a range of $4.60 to $4.80, an increase from the previous guidance of $4.25 to $4.45.
• The company's operating ROE is expected to exceed its three-year target of 12%, reaching 13.1% as of June 30, 2026.
• Total insurance product margin increased to $279.0 million in Q2 2026 from $252.4 million in Q2 2025.
• Net investment income increased by 8% in Q2 2026 to $327.5 million, attributed to business growth and higher alternative investment income.
• The company is on track with its TechMod initiative, a three-year project to modernize technology, with $76 million expected in 2026.
• CNO Financial Group is exiting its fee services business within the Worksite Division, a move expected to reduce annual fee revenue by approximately $30 million but increase annual pre-tax income by roughly $20 million.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively, reflecting improved operating earnings and a raised full-year guidance, indicating a strengthening financial performance and positive outlook.

Positives

• Net income increased by 37% year-over-year for the second quarter and 45% for the first six months of 2026.
• Raised full-year operating earnings per diluted share guidance to $4.60-$4.80.
• Operating ROE improved to 13.1% as of June 30, 2026, exceeding the 12% target.
• Insurance product margin saw a notable increase in both the second quarter and year-to-date periods.
• Net investment income grew by 8% in Q2 2026, driven by business expansion and improved alternative investment performance.
• The company maintained strong financial strength ratings from major agencies (Moody's, AM Best, Fitch, S&P) with stable outlooks.
• Consolidated statutory RBC ratio remained strong at 377% as of June 30, 2026, within the target range.
• The company is managing its capital effectively, with a debt-to-total capital ratio (excluding AOCI) of 26.1% as of June 30, 2026.

Negatives

• The company's operating ROE of 10.9% as of June 30, 2026, was slightly down from 11.9% in the prior year, although the adjusted operating ROE improved.
• Net Consumer Division fee income decreased from income of $7.4 million in Q2 2025 to a loss of $1.2 million in Q2 2026, primarily due to a shift in customer preference away from Medicare Advantage products.
• The company is exiting its fee services business, which will reduce annual fee revenue by approximately $30 million, although this is expected to be offset by increased pre-tax income.

Risks

• The company faces risks related to general economic, market, and political conditions, including inflation and market volatility, which could impact investment values and the ability to raise capital.
• Exposure to interest rate risk and future investment results, including potential realized losses and impairments, could negatively impact profitability and liquidity.
• The outcome of ongoing lawsuits and regulatory proceedings is uncertain and could have a material adverse effect on the company's financial condition.
• Changes in accounting principles and interpretations could affect reported amounts.
• The company's ability to obtain adequate and timely rate increases on its health products is subject to regulatory approval and market conditions.
• The company is subject to significant regulatory oversight, and changes in regulations could impact its operations and financial condition.
• The failure of reinsurers to perform their obligations could negatively impact earnings and financial position.
• Cybersecurity risks and data breaches remain a concern.

Future Outlook

The company has raised its full-year 2026 operating earnings per diluted share guidance to a range of $4.60 to $4.80. The expense ratio is expected to be between 18.8% and 19.0%. Fee income is projected to be approximately $30 million for the year, with a reduced contribution in the third quarter due to the exit of the Worksite Division fee services business. The effective tax rate assumption has been lowered to approximately 21.5%. The company expects its operating ROE to exceed its three-year target of 12%. Free cash flows are projected to be in the range of $200 million to $250 million. The company expects to maintain a consolidated RBC ratio between 360% and 390% for its U.S. insurance subsidiaries, minimum holding company liquidity of $150 million, and a debt to total capital ratio (excluding AOCI) between 25% and 28%.

Management Comments

• StockSavvy.ai notes that the company's strong first-half results and confidence in the underlying performance of the business have led to an increase in operating earnings per diluted share guidance.
• Management believes that the exit from the fee services business will sharpen the company's focus on its core insurance business and is expected to increase annual pre-tax income.
• The company is disciplined with its marketing expenditures and will increase or decrease its marketing spend depending on the current economics of the purchase or other factors, including the effectiveness of advertising spend.

Industry Context

StockSavvy.ai observes that CNO Financial Group's performance aligns with a trend of insurers focusing on core insurance products and improving operational efficiency. The company's strategic exit from non-core fee services aligns with industry efforts to streamline operations and enhance profitability. The increase in investment income reflects a broader market trend of higher yields, though insurers remain cautious about interest rate volatility.

Comparison to Industry Standards

• CNO's operating ROE of 13.1% (adjusted) is competitive within the life and annuity insurance sector, where companies often aim for ROEs in the low to mid-teens.
• The company's consolidated statutory RBC ratio of 377% is well above the typical regulatory minimums and industry averages, indicating a strong capital position.
• The company's focus on the middle-income, pre-retiree, and retired American market segments is a strategic focus for many insurers seeking stable, long-term growth opportunities.
• The company's investment portfolio, while diversified, includes a significant portion in fixed maturities, which is standard for the industry, with a focus on managing credit and interest rate risk.

Legal Proceedings

• The case of Burnett v. Conseco Life Ins. Co. remains pending against the CNO Entities, with a bench trial on alter ego liability having concluded but no ruling yet made.
• The company is subject to various regulatory examinations and inquiries in the ordinary course of business, the outcomes of which cannot be predicted with certainty.

Stakeholder Impact

• Shareholders are likely to benefit from the improved financial performance, raised guidance, and continued share repurchase program.
• Policyholders may see continued stability in product offerings, with the company focusing on its core insurance business.
• Employees may be impacted by the exit of the fee services business, though the overall focus on core insurance could lead to strategic growth opportunities.

Next Steps

• Continue to manage the business with a focus on core insurance products.
• Monitor and manage investment portfolio risks, including credit and interest rate exposures.
• Execute on the modernization of technology through the TechMod initiative.
• Evaluate the impact of exiting the fee services business and realize expected pre-tax income improvements.
• Continue to manage capital efficiently, maintaining strong RBC ratios and liquidity levels.
• Monitor regulatory developments, particularly concerning Big Data and Artificial Intelligence.

Key Dates

Recommendation

While the company shows improved financial performance and raised guidance, the slight decrease in reported ROE and the ongoing legal proceedings introduce some uncertainty. The strategic shift towards core insurance products is positive, but the market's reaction to the fee services exit and the resolution of legal matters will be key factors. A 'hold' recommendation reflects a balanced view of the current positive momentum and existing risks.

Keywords

insurance, annuity, life insurance, health insurance, investment income, financial services, fixed maturities, shareholders' equity